Development of β-cyclodextrin-based sustained release microparticles for oral insulin delivery

References

• King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414–31
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. National Diabetes Statistics report 2014. Available from: www.cdc.gov/diabetes/pubs/statsreport14
   Google Scholar
• Pillay TS, Makgoba MW. Molecular mechanisms of insulin resistance. S Afr Med J 1991;79:607–13
   PubMed Web of Science ®Google Scholar
• Hamilton-Shield JP. Overview of neonatal diabetes. Endocr Dev 2007;12:12–23
   PubMedGoogle Scholar
• Korsgren O, Nilsson B. Improving islet transplantation: a road map for a widespread application for the cure of persons with type I diabetes. Curr Opin Organ Transplant 2009;14:683–7
   PubMed Web of Science ®Google Scholar
• Heinemann L. New ways of insulin delivery. Int J Clin Pract Suppl 2010;166:29–40
   PubMedGoogle Scholar
• Klonoff DC. Technological advances in the treatment of diabetes mellitus: better bioengineering begets benefits in glucose measurement, the artificial pancreas, and insulin delivery. Pediatr Endocrinol Rev 2003;1:94–100
   PubMedGoogle Scholar
• Clement S, Dandona P, Still JG, Kosutic G. Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial. Metabolism 2004;53:54–8
   PubMed Web of Science ®Google Scholar
• Hinds KD, Campbell KM, Holland KM, et al. PEGylated insulin in PLGA microparticles: in vivo and in vitro analysis. J Control Release 2005;104:447–60
   PubMed Web of Science ®Google Scholar
• Hoffman A, Qadri B. Eligen insulin – a system for the oral delivery of insulin for diabetes. IDrugs 2008;11:433–41
   PubMed Web of Science ®Google Scholar
• Krishnankutty RK, Mathew A, Sedimbi SK, et al. Alternative routes of insulin delivery. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2009;34:933–48
   PubMedGoogle Scholar
• Henkin RI. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action. Nutrition 2010;26:33–9
   PubMed Web of Science ®Google Scholar
• Ma EL, Ma H, Liu Z, et al. In vitro and in vivo evaluation of a novel oral insulin formulation. Acta Pharmacol Sin 2006;27:1382–8
   PubMed Web of Science ®Google Scholar
• Geho WB, Geho HC, Lau JR, Gana TJ. Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation. J Diabetes Sci Technol 2009;3:1451–9
   PubMedGoogle Scholar
• Klingler C, Muller BW, Steckel H. Insulin-micro- and nanoparticles for pulmonary delivery. Int J Pharm 2009;377:173–9
   PubMed Web of Science ®Google Scholar
• Fix JA. Oral controlled release technology for peptides: status and future prospects. Pharm Res 1996;13:1760–4
   PubMed Web of Science ®Google Scholar
• Lee HJ. Protein drug oral delivery: the recent progress. Arch Pharm Res 2002;25:572–84
   PubMed Web of Science ®Google Scholar
• Hamman JH, Enslin GM, Kotze AF. Oral delivery of peptide drugs: barriers and developments. Bio Drugs 2005;19:165–77
   Google Scholar
• Vanbever R, Mintzes JD, Wang J, et al. Formulation and physical characterization of large porous particles for inhalation. Pharm Res 1999;16:1735–42
   PubMed Web of Science ®Google Scholar
• Jones AK, Bejugam NK, Nettey H, et al. Spray-dried doxorubicin-albumin microparticulate systems for treatment of multidrug resistant melanomas. J Drug Target 2010;19:427–33
   PubMed Web of Science ®Google Scholar
• Uddin AN, Bejugam NK, Gayakwad SG, et al. Oral delivery of gastro-resistant microencapsulated typhoid vaccine. J Drug Target 2009;17:553–60
   PubMed Web of Science ®Google Scholar
• Delie F, Blanco-Prieto MJ. Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules 2005;10:65–80
   PubMed Web of Science ®Google Scholar
• Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000;21:2475–90
   PubMed Web of Science ®Google Scholar
• Ye M, Kim S, Park K. Issues in long-term protein delivery using biodegradable microparticles. J Control Release 2010;146:241–60
   PubMed Web of Science ®Google Scholar
• Daoud-Mahammed S, Grossiord JL, Bergua T, Amiel C. Self-assembling cyclodextrin based hydrogels for the sustained delivery of hydrophobic drugs. J Biomed Mater Res A 2008;86:736–48
   PubMed Web of Science ®Google Scholar
• Hamishehkar H, Emami J, Najafabadi AR, et al. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin. Int J Pharm 2010;389:74–85
   PubMed Web of Science ®Google Scholar
• Maltesen MJ, Bjerregaard S, Hovgaard L, et al. Quality by design - Spray drying of insulin intended for inhalation. Eur J Pharm Biopharm 2008;70:828–38
   PubMed Web of Science ®Google Scholar
• Qian F, Mathias N, Moench P, et al. Pulmonary delivery of a GLP-1 receptor agonist, BMS-686117. Int J Pharm 2009;366:218–20
   PubMed Web of Science ®Google Scholar
• Jayanthan A, Incoronato A, Singh A, et al. Cytotoxicity drug combinability and biological correlates of ABT-737 against acute lymphoblastic leukemia cells with MLL rearrangement. Pediatr Blood Cancer 2011;56:353–60
   PubMed Web of Science ®Google Scholar
• Schmidt C, Höcherl K, Bucher M. Regulation of renal glucose transporters during severe inflammation. Am J Physiology 2007;292:804–11
   Google Scholar
• Bhowmik T, D'Souza B, Uddin MN, D'Souza MJ. Oral delivery of microparticles containing plasmid DNA encoding hepatitis B surface antigen. J Drug Target 2012;20:364–71
   PubMed Web of Science ®Google Scholar
• Sarmento B, Ribeiro A, Veiga F, et al. Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 2007;8:3054–60
   PubMed Web of Science ®Google Scholar
• Eldridge JH, Meulbroek JA, Staas JK, et al. Vaccine-containing biodegradable microspheres specifically enter the gut-associated lymphoid tissue following oral administration and induce a disseminated mucosal immune response. Adv Exp Med Biol 1989;251:191–202
   PubMedGoogle Scholar
• Sajeesh S, Bouchem K, Marsaud V, et al. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: an oral delivery system for insulin. J Control Release 2010;147:377–84
   PubMed Web of Science ®Google Scholar
• Pessin JE, Saltiel AR. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 2000;106:165–9
   PubMed Web of Science ®Google Scholar
• Petersen K, Shulman GI. Cellular mechanism of insulin resistance in skeletal muscle. J R Soc Med 2002;95:8–13
   PubMed Web of Science ®Google Scholar